SpringerLink
Log in

Oral Oncology

  • Chapter
  • First Online:
Head and Neck Cancer

Abstract

This chapter describes current maxillofacial prosthetic rehabilitation concepts for the head and neck cancer patient and oral complications that can result from oncologic therapy. Head and neck cancer treatment can result in complex oral and dental sequelae. The complications vary by patient and depend on the individual’s oral and dental status, malignancy, and treatment rendered. Oral complications can be minimized if patient education is implemented early in intervention and prevention is optimized. Oral oncology specialist can have an important role on the head and neck multidisciplinary team in supportive care therapy and maxillofacial prosthetic rehabilitation.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
EUR 29.95
Price includes VAT (Germany)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
EUR 213.99
Price includes VAT (Germany)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
EUR 267.49
Price includes VAT (Germany)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free ship** worldwide - see info
Hardcover Book
EUR 267.49
Price includes VAT (Germany)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free ship** worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Toth BB, Chambers MS, Fleming TJ, Lemon JC, Martin JW. Minimizing oral complications of cancer treatment. Oncology. 1995;9(9):851–8.

    CAS  PubMed  Google Scholar 

  2. Chambers MS, Toth BB, Martin JW, Fleming TJ, Lemon JC. Oral and dental management of the cancer patient: prevention and treatment of complications. Support Care Cancer. 1995;3(3):168–75.

    Article  CAS  PubMed  Google Scholar 

  3. Westcott WB. Dental management of patients being treated for oral cancer. Calif Dent Assoc J. 1985;13(5):42–7.

    Google Scholar 

  4. Westcott WB. Dental management of patients being for oral cancer. JAM Dent Assoc. 1995;111:49–54.

    Google Scholar 

  5. Peterson DE. Dental care for the cancer patient. Compend Contin Educ Dent. 1983;4(2):115–20.

    CAS  PubMed  Google Scholar 

  6. Rahn AO, Goldman BM, Parr GR. Prosthodontic principles in surgical planning for maxillary and mandibular resection patients. J Prosthet Dent. 1979;42(4):429–33.

    Article  CAS  PubMed  Google Scholar 

  7. Beumer J, Nishimura R, Roumanas E. Maxillary defects: alterations at surgery which enhance the prosthetic prognosis. In: Proceedings of 1st International Congress on Maxillofacial Prosthetics; 1995. p. 22–26.

    Google Scholar 

  8. Jacob RF, Martin JW, King GE. Modification of surgical obturators to interim prostheses. J Prosthet Dent. 1985;54(1):93–5.

    Article  CAS  PubMed  Google Scholar 

  9. Jacob R. Prosthodontic rehabilitation of the mandibulectomy patient. In: Taylor T, editor. Clinical maxillofacial prosthetics. Chicago: Quintessence Publishing Co; 2000. p. 171–88.

    Google Scholar 

  10. Foster RD, Anthony JP, Sharma A. Vascularized bone flaps versus non vascularized bone grafts for mandibular reconstruction: an endosseous implant success. Head Neck. 1992;21(1):66–71.

    Article  Google Scholar 

  11. El R, Dixon SF. Free flap complications: when it’s enough, enough? Curr Opin Otolaryngol Head Neck Surg. 2003;11(4):236–9.

    Article  Google Scholar 

  12. Desjardins RP. Occlusal considerations for the partial mandibulectomy patient. JPD. 1979;41(3):308–15.

    CAS  Google Scholar 

  13. Smolka K, Kraehenbuehl M, Eggesperger N, et al. Fibula free flap reconstruction of the mandible in cancer patients: evaluation of combined surgical and prosthodontic treatment concept. Oral Oncol. 2008;44(6):571–81.

    Article  PubMed  Google Scholar 

  14. Urken ML, Buchbinder D, Constantino PD, et al. Oromandibular reconstruction using microvascular composite flaps. Arch Otolaryngol Head Neck Surg. 1998;124(1):46–55.

    Article  CAS  PubMed  Google Scholar 

  15. Holmes J, Aponte Wesson R. Dental implants after reconstruction with free tissue transfer. Oral Maxillofac Surg Clin North Am. 2010;22(10):407–18.

    Article  PubMed  Google Scholar 

  16. Rentschler GJ, Mann MB. The effects of glossectomy on intelligibility of speech and oral perceptual discrimination. J Oral Surg. 1980;38(5):348–54.

    CAS  PubMed  Google Scholar 

  17. Cantor R. Maxillary speech prostheses for mandibular surgical defects. J Prosthet Dent. 1969;22(2):253–60.

    Article  CAS  PubMed  Google Scholar 

  18. Robbins KT, Bowman JB, Jacob RF, et al. Post glossectomy deglutition and articulation rehabilitation with palatal augmentation prosthesis. Arch Otololaryngol Head Neck Surg. 1987;113:1214–8.

    Article  CAS  Google Scholar 

  19. Davis JW, Lazarus C, Logeman J. Effect of a maxillary glossectomy prosthesis on articulation and swallowing. JPD. 1990;64:701.

    Google Scholar 

  20. Kaanders J, Fleming T. Devices valuable in head and neck radiotherapy. Int J Radiat Oncol Biol Phys. 1992;23(3):639–45.

    Article  CAS  PubMed  Google Scholar 

  21. Fleming TJ, Rambach SC. A tongue-shielding radiation stent. J Prosthet Dent. 1983;49(3):389–92.

    Article  CAS  PubMed  Google Scholar 

  22. Andres CH, Haug SP. Facial prosthesis fabrication: technical aspects. In: Taylor T, editor. Clinical maxillofacial prosthetics. Chicago: Quintessence Publishing Co; 2000. p. 233–44.

    Google Scholar 

  23. McKinstry R. Raymond Allen. Fundamentals in facial prosthetics. Chapter 11. Arlington, VA: ABI Professional Publications; 1995.

    Google Scholar 

  24. Beumer J, Manirick MT, Esposito SJ. Rehabilitation of facial defects. Chapter 5. Chicago: Quintessence Publishing Co; 2011. p. 255–313.

    Google Scholar 

  25. Haug SP, Andres CJ, Munoz CA, Okamura M. Effects of environmental factors on maxillofacial elastomers: part III—physical properties. J Prosthet Dent. 1992;68(4):644–51.

    Article  CAS  PubMed  Google Scholar 

  26. Kiat-amnuay S, Gettleman L, Khan Z, Goldsmith LJ. Effect of adhesive retention on maxillofacial prostheses. Part I: skin dressings and solvent removers. J Prosthet Dent. 2000;84(3):335–40.

    Article  CAS  PubMed  Google Scholar 

  27. Udagama A. Urethane–lined silicone facial prosthesis. J Prosthet Dent. 1987;58:351–4.

    Article  CAS  PubMed  Google Scholar 

  28. Chambers MS, Lemon JC, Martin JW. Surgical techniques to enhance prosthetic rehabilitation. In: Bailey BJ, Johnson JT Newlands S, editors. Head and neck surgery-otolaryngology. 4th ed. Chapter 127. Philadelphia, PA: Lippincott Williams and Wilkins; 2006. p. 1851–865.

    Google Scholar 

  29. Lemons JC, Chambers MS. Conventional methods of retention of facial prosthesis. First Int Congress Max Fac Prosthet. 1994;1:116–9.

    Google Scholar 

  30. Scully C, Epstein JB. Oral health care for the cancer patient. Eur J Cancer B Oral Oncol. 1996;32B:281–92.

    Article  CAS  PubMed  Google Scholar 

  31. Sonis ST, Elting LS, Keefe D, et al. Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients. Cancer. 2004;100(9 Suppl):1995–2025.

    Article  PubMed  Google Scholar 

  32. Sonis S, Clark J. Prevention and management of oral mucositis induced by antineoplastic therapy. Oncol (Hunting). 1991;5:11–8.

    CAS  Google Scholar 

  33. Rubenstein EB, Peterson DE, Schubert M, et al. Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis. Cancer. 2004;100(9 Suppl):2026–46.

    Article  PubMed  Google Scholar 

  34. Chambers MS, Rosenthal DI, Weber RS. Radiation-induced xerostomia. Head Neck. 2007;29(1):58–63.

    Article  PubMed  Google Scholar 

  35. Parulekar W, Mackenzie R, Bjarnason G, Jordan RC. Scoring oral mucositis. Oral Oncol. 1998;34:63–71.

    Article  CAS  PubMed  Google Scholar 

  36. Sonis ST, Eilers JP, Epstein JB, et al. Validation of a new scoring system for the assessment of the clinical trial research of oral mucositis induced by radiation or chemotherapy. Cancer. 1999;85:2103–13.

    Article  CAS  PubMed  Google Scholar 

  37. Sonis S, Fazio RC, Fang L. Principles and practice of oral medicine. Philadelphia: W B Saunders Company; 1984.

    Google Scholar 

  38. Clarkson JE, Worthington HV, Eden OB. Interventions for preventing oral mucositis for patients with cancer receiving treatment (Cochrane Review). In: The Cochrane Library, Issue 4. Chichester: Wiley; 2003.

    Google Scholar 

  39. Guchelaar HJ, Vermes A, Meerwaldt JH. Radiation-induced xerostomia: pathophysiology, clinical course and supportive treatment. Support Care Cancer. 1997;5:281–8.

    Article  CAS  PubMed  Google Scholar 

  40. Chambers MS, Garden AS, Kies MS, Martin JW. Radiation-induced xerostomia in patients with head and neck cancer: pathogenesis, impact on quality of life, and management. Head Neck. 2004;26(9):796–807.

    Article  PubMed  Google Scholar 

  41. Chambers MS, Garden AS, Lemon JC, Kies MS, Martin JW. Oral complications of cancer treatment. In: Davies A, Finlay I, editors. Oral care in advanced disease. Oxford: Oxford University Press; 2005. p. 171–84.

    Google Scholar 

  42. Brizel DM, Wasserman TH, Henke M, et al. Phase III randomized trial of amifostine as a radioprotector in head and neck cancer. J Clin Oncol. 2000;18:3339–45.

    CAS  PubMed  Google Scholar 

  43. Davies AN. The management of xerostomia: a review. Eur J Cancer Care. 1997;6:209–14.

    Article  CAS  Google Scholar 

  44. Store G, Boysen M. Mandibular osteoradionecrosis: clinical behavior and diagnostic aspects. Clin Otolaryngol. 2000;25:378–84.

    Article  CAS  PubMed  Google Scholar 

  45. Marx RE. Osteonecrosis: a new concept of it pathophysiology. J Oral Maxillofac Surg. 1983;41(5):283–8.

    Article  CAS  PubMed  Google Scholar 

  46. Marx RE, Johnson RP. Studies in the radiobiology of osteonecrosis and their clinical significance. Oral Surg Oral Med Oral Pathol. 1987;64:379–86.

    Article  CAS  PubMed  Google Scholar 

  47. Marx RE, Johnson RP, Kline SN. Prevention of osteoradionecrosis: a randomized prospective clinical trial of hyperbaric oxygen versus penicillin. J Am Dent Assoc. 1985;111:49–54.

    Article  CAS  PubMed  Google Scholar 

  48. Jereczek-Fossa BA, Orecchia R. Radiotherapy-induced mandibular bone complications. Cancer Treat Rev. 2002;28:65–74.

    Article  PubMed  Google Scholar 

  49. Feldmeier JJ, Hampson NB. A systematic review of the literature reporting the application of hyperbaric oxygen prevention and treatment of delayed radiation injuries: an evidence based approach. Undersea Hyperb Med. 2002;29:4–30.

    CAS  PubMed  Google Scholar 

  50. Delanian S. Major healing of refractory mandible osteonecrosis after treatment combining pentoxifylline-tocopherol. A phase II trial. Head Neck. 2005;27:114–23.

    Article  PubMed  Google Scholar 

  51. Notani K, Yamazaki Y, Kitada H, Sakakibara N, Fukuda H, Omori K, et al. Management of mandibular osteoradionecrosis corresponding to the severity of osteoradionecrosis and the method of radiotherapy. Head Neck. 2003;25:181–6.

    Article  PubMed  Google Scholar 

  52. Chang DW, Oh HK, Robb GL, Miller MJ. Management of advanced mandibular osteoradionecrosis with free flap reconstruction. Head Neck. 2001;23:830–5.

    Article  CAS  PubMed  Google Scholar 

  53. Martin JW, Chambers MS, Lemon JC. Dental oncology and maxillofacial prosthetics. In: Harrison LB, Sessions RB, Hong WK, editors. Head and neck center: a multidisciplinary approach. Philadelphia: Lippincott Williams and Wilkins; 2004. p. 115–29.

    Google Scholar 

  54. Elting LS, Cooksley C, Chambers MS, Cantor SB, Manzullo E, Rubenstein EB. The burdens of cancer therapy: clinical and economic outcomes of chemotherapy-induced mucositis. Cancer. 2003;98:1531–9.

    Article  PubMed  Google Scholar 

  55. Ruggiero SL, Fantasia J, Carlson E. Bisphosphonate-related osteonecrosis of the jaw: background and guidelines for diagnosis staging and management. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006;102:433.

    Article  PubMed  Google Scholar 

  56. Van den Wyngaert T, Claeys T, Huizing MT, et al. Initial experience with conservative treatment in cancer patients with osteonecrosis of the jaw (ONJ) and predictors of outcome. Ann Oncol. 2009;20:331.

    Article  PubMed  Google Scholar 

  57. Kyle RA, Yee GC, Somerfield MR, et al. Clinical practice guidelines update on the role of bisphosphonates in multiple myeloma. American Society of Clinical Oncology 2007. J Clin Oncol. 2007;25:2464–72.

    Article  CAS  PubMed  Google Scholar 

  58. Marx RE. Oral and intravenous bisphosphonate-induced osteonecrosis of the jaws. Chicago: Quintessence; 2007.

    Google Scholar 

  59. Ruggiero SL, et al. American association of oral and maxillofacial surgeons position paper on bisphosphonate-related osteonecrosis of the jaws—2009 update. J Oral Maxillofac Surg. 2009;67:2.

    Article  PubMed  Google Scholar 

  60. Ruggiero SL, et al. American association of oral and maxillofacial surgeons position paper on medication-related osteonecrosis of the jaws—2014 update. J Oral Maxillofac Surg. 2014;72(10):1938–56.

    Article  PubMed  Google Scholar 

  61. Marx RE. Oral and intravenous bisphosphonate induced osteonecrosis of the jaws: history, etiology, prevention and treatment. 2nd ed. Hanover Park, IL: Quintessence; 2011.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Section of Oral Oncology and Maxillofacial Prosthodontics, Department of Head and Neck Surgery, Division of Surgery, MD Anderson Cancer Center, 1400 Pressler St., #1445, Houston, TX, 77030, USA

    Ruth Aponte Wesson DDS, MS, FACP, Theresa M. Hofstede DDS, FACP, Richard C. Cardoso DDS, MS, FACP, Pattii Montgomery, Alexander M. Won DDS, Jack W. Martin DDS, MS & Mark S. Chambers DM, DMS

Authors
  1. Ruth Aponte Wesson DDS, MS, FACP
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Theresa M. Hofstede DDS, FACP
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Richard C. Cardoso DDS, MS, FACP
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Pattii Montgomery
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Alexander M. Won DDS
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Jack W. Martin DDS, MS
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Mark S. Chambers DM, DMS
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mark S. Chambers DM, DMS .

Editor information

Editors and Affiliations

  1. Department of Radio-Oncology, Genolier Swiss Medical Network, Genolier, Switzerland

    Jacques Bernier

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Wesson, R.A. et al. (2016). Oral Oncology. In: Bernier, J. (eds) Head and Neck Cancer. Springer, Cham. https://doi.org/10.1007/978-3-319-27601-4_25

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-27601-4_25

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-27599-4

  • Online ISBN: 978-3-319-27601-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation